{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:48:04Z","timestamp":1788184084595,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.trim.2025.102231","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:20:49Z","timestamp":1746724849000},"page":"102231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The impact of ABO compatibility\/incompatibility between donor and recipient of allogeneic bone marrow transplant on transplant outcomes"],"prefix":"10.1016","volume":"91","author":[{"given":"Ehsan","family":"Yazdandoust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Hajifathali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Teimourpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Amini-Kafiabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Roshandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.trim.2025.102231_bb0005","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41409-019-0516-2","article-title":"Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019","volume":"54","author":"Duarte","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2025.102231_bb0010","first-page":"127","article-title":"Late complications of allogeneic and autologous marrow transplantation","volume":"10","author":"Sullivan","year":"1992","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2025.102231_bb0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2016.160804","article-title":"Impact of ABO incompatibility on patients\u2019 outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the Acute Leukemia Working Party of the EBMT","volume":"102","author":"Canaani","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.trim.2025.102231_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.htct.2018.05.007","article-title":"Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study","volume":"41","author":"Soares","year":"2019","journal-title":"Hematology, Transfusion and Cell Therapy"},{"issue":"1","key":"10.1016\/j.trim.2025.102231_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000441507","article-title":"ABO-mismatched allogeneic hematopoietic stem cell transplantation","volume":"43","author":"Worel","year":"2016","journal-title":"Transfus. Med. Hemother."},{"issue":"9","key":"10.1016\/j.trim.2025.102231_bb0030","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbmt.2010.03.021","article-title":"Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source","volume":"16","author":"Blin","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.trim.2025.102231_bb0035","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3324\/haematol.12933","article-title":"Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program","volume":"93","author":"Kimura","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.trim.2025.102231_bb0040","article-title":"Prevalence of pure red cell aplasia following major ABO-incompatible hematopoietic stem cell transplantation","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.trim.2025.102231_bb0045","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/bjh.12210","article-title":"Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation","volume":"160","author":"Aung","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.trim.2025.102231_bb0050","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/bmt.2013.8","article-title":"Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation","volume":"48","author":"Romee","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.trim.2025.102231_bb0055","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.bbmt.2009.07.002","article-title":"Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients","volume":"15","author":"Ludajic","year":"2009","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation."},{"issue":"9","key":"10.1016\/j.trim.2025.102231_bb0060","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbmt.2010.03.021","article-title":"Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source","volume":"16","author":"Blin","year":"2010","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation."},{"issue":"9","key":"10.1016\/j.trim.2025.102231_bb0065","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41409-024-02316-0","article-title":"Donor\/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigens","volume":"59","author":"Xhaard","year":"2024","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2025.102231_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.08073.x","article-title":"The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation","volume":"149","author":"Wang","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.trim.2025.102231_bb0075","doi-asserted-by":"crossref","first-page":"1386670","DOI":"10.3389\/fonc.2024.1386670","article-title":"Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review","volume":"14","author":"Metafuni","year":"2024","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.trim.2025.102231_bb0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2141.2005.05364.x","article-title":"Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation","volume":"128","author":"Griffith","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.trim.2025.102231_bb0085","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbmt.2013.02.001","article-title":"Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study","volume":"19","author":"Pidala","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2025.102231_bb0090","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2016.160804","article-title":"Impact of ABO incompatibility on patients\u2019 outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT","volume":"102","author":"Canaani","year":"2017","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.trim.2025.102231_bb0095","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0b013e31826c39b2","article-title":"Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation","volume":"94","author":"Berglund","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2025.102231_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102696","article-title":"Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation","volume":"59","author":"Parkhideh","year":"2020","journal-title":"Transfus. Apher. Sci."},{"issue":"6","key":"10.1016\/j.trim.2025.102231_bb0105","first-page":"331","article-title":"Impact of donor-to-recipient ABO mismatch on outcomes of antithymocyte globulin-based peripheral blood stem cell-derived myeloablative conditioning haploidentical stem cell transplantation","volume":"28","author":"Wu","year":"2022","journal-title":"Transplant Cell Ther."},{"issue":"7","key":"10.1016\/j.trim.2025.102231_bb0110","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbmt.2013.04.004","article-title":"Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors","volume":"19","author":"Hirokawa","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2025.102231_bb0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1702121","article-title":"Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation","volume":"25","author":"Lee","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2025.102231_bb0120","article-title":"Prevalence of pure red cell aplasia following major ABO-incompatible hematopoietic stem cell transplantation","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2025.102231_bb0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.17463","article-title":"Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study","volume":"193","author":"Longval","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.trim.2025.102231_bb0130","article-title":"ABO mismatch in allogeneic hematopoietic stem cell transplant: effect on short- and long-term outcomes","volume":"7","author":"Valentini","year":"2021","journal-title":"Transplant. Direct"},{"issue":"1","key":"10.1016\/j.trim.2025.102231_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.06.024","article-title":"Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation","volume":"59","author":"Ciftciler","year":"2020","journal-title":"Transfus. Apher. Sci."},{"issue":"2","key":"10.1016\/j.trim.2025.102231_bb0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbmt.2013.11.011","article-title":"Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning","volume":"20","author":"Watz","year":"2014","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation."},{"key":"10.1016\/j.trim.2025.102231_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.12659\/AOT.916004","article-title":"ABO blood type incompatibility is not a risk factor of outcomes for acute myeloid leukemia (AML) patients after unmanipulated haplo-identical peripheral blood hematopoietic stem cell transplantation","volume":"24","author":"Yang","year":"2019","journal-title":"Ann. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2025.102231_bb0150","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1111\/trf.15531","article-title":"RBC and platelet transfusion support in the first 30 and 100days after haploidentical hematopoietic stem cell transplantation","volume":"59","author":"Yuan","year":"2019","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.trim.2025.102231_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/trf.14966","article-title":"Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993\u20132010): factors that predict intensity and time to transfusion independence","volume":"59","author":"Griffith","year":"2019","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.trim.2025.102231_bb0160","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41409-020-0939-9","article-title":"Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series","volume":"55","author":"Gomez-Arteaga","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2025.102231_bb0165","doi-asserted-by":"crossref","first-page":"1212007","DOI":"10.3389\/fimmu.2023.1212007","article-title":"Case report: successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease","volume":"14","author":"Dovern","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2025.102231_bb0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/ejh.14341","article-title":"Daratumumab in the management of red cell aplasia following allogeneic hematopoietic stem cell transplantation","volume":"114","author":"Desai","year":"2025","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.trim.2025.102231_bb0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41409-024-02479-w","article-title":"The role of daratumumab in complications post-allogeneic hematopoietic stem cell transplantation: a single-center prospective study on PRCA and AIHA","volume":"60","author":"Giammarco","year":"2025","journal-title":"Bone Marrow Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:45:14Z","timestamp":1762346714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327425000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":35,"alternative-id":["S0966327425000590"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2025.102231","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of ABO compatibility\/incompatibility between donor and recipient of allogeneic bone marrow transplant on transplant outcomes","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2025.102231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102231"}}